NASDAQ:NVIV InVivo Therapeutics (NVIV) News Today $1.31 -0.01 (-0.76%) (As of 05/31/2023 ET) Add Compare Share Share Today's Range$1.28▼$1.3350-Day Range$0.90▼$1.4752-Week Range$0.81▼$13.77Volume20,810 shsAverage Volume75,755 shsMarket Capitalization$4.07 millionP/E RatioN/ADividend YieldN/APrice TargetN/A HeadlinesProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Get InVivo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NVIV and its competitors with MarketBeat's FREE daily newsletter. Email Address NVIV Media Mentions By Week NVIV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVIV News Sentiment▼0.960.79▲Average Medical News Sentiment NVIV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVIV Articles This Week▼30▲NVIV Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineInVivo Therapeutics (NASDAQ:NVIV) Now Covered by StockNews.comamericanbankingnews.com - May 26 at 3:48 AMInVivo Therapeutics (NASDAQ:NVIV) Coverage Initiated at StockNews.comamericanbankingnews.com - May 17 at 5:20 AMInVivo Therapeutics (NASDAQ:NVIV) Earns Sell Rating from Analysts at StockNews.comamericanbankingnews.com - May 2 at 2:44 AMRing Therapeutics Strengthens Executive Team with Appointment of Christopher McNulty as Chief Financial Officer, Head of Corporate Strategybenzinga.com - May 1 at 12:30 PMInVivo Therapeutics (NASDAQ:NVIV) Coverage Initiated by Analysts at StockNews.comamericanbankingnews.com - April 15 at 7:28 AMWhy InVivo Therapeutics Shares Are Plunging Todayfinance.yahoo.com - March 17 at 1:53 AMInVivo seeks longer-term control in Casino-Teract retail tie-upmsn.com - March 10 at 6:45 PMWhy Barnes & Noble Education Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarketmsn.com - March 10 at 6:45 PMU.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.66%msn.com - March 10 at 3:10 AMWhy JD.com Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionmsn.com - March 9 at 5:08 PMInVivo : INSPIRE 2.0 Study In Acute Spinal Cord Injury Fails To Meet Primary Endpointmarkets.businessinsider.com - March 9 at 5:08 PMInVivo to evaluate strategic options as trial for spinal injury device failsmsn.com - March 9 at 5:08 PMInVivo Therapeutics Shares Hit 52-Week Low After Study Misses Primary Endpointmarketwatch.com - March 9 at 5:08 PMInVivo Therapeutics Study for Neuro-Spinal Scaffold Misses Primary Endpointmarketwatch.com - March 9 at 9:54 AMInVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injuryfinance.yahoo.com - March 9 at 9:54 AMmarketbeat.com - March 9 at 8:51 AMInVivo Therapeutics Hldg Stock (NASDAQ:NVIV), Quotes and News Summarybenzinga.com - January 11 at 8:35 PMInVivo Therapeutics Announces Closing of $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rulesfinance.yahoo.com - October 11 at 6:58 PMInVivo Therapeutics Shares Continue Friday's Fall, Hit All-Time Intraday Lowmarketwatch.com - October 10 at 1:53 PMInVivo Therapeutics dips 24% on $9M direct and private placement offeringsseekingalpha.com - October 7 at 1:56 PMInVivo Therapeutics Stock Drops on $9 Million Offeringmarketwatch.com - October 7 at 1:56 PMWhy Is InVivo Therapeutics (NVIV) Stock Down 34% Today?investorplace.com - October 7 at 11:00 AMInVivo Therapeutics Announces $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rulesfinance.yahoo.com - October 7 at 8:55 AMmarketbeat.com - October 6 at 3:47 PMInVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright 24th Annual Global Investment Conferencefinance.yahoo.com - September 9 at 8:12 AMInVivo Therapeutics Holdings Corp. (NVIV)uk.finance.yahoo.com - August 28 at 8:41 PMmarketbeat.com - August 5 at 9:49 AMmarketbeat.com - August 4 at 10:47 AMmarketbeat.com - August 4 at 10:18 AMmarketbeat.com - August 4 at 10:07 AMmarketbeat.com - August 4 at 9:57 AMmarketbeat.com - August 4 at 9:44 AMInVivo Therapeutics Announces Appointment of Heather M. Hamel as Chief Legal Officer and General Counselfinance.yahoo.com - July 13 at 9:32 AMInVivo Therapeutics Announces Publication of 12- and 24-month Data for INSPIRE 1.0 Study in Peer-Reviewed Neurosurgeryfinance.yahoo.com - June 8 at 9:06 AMInVivo Therapeutics Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal Cord Injury Studyfinance.yahoo.com - June 2 at 11:49 AMWhy Are InVivo Therapeutics Shares Trading Lower During Premarket Monday?finance.yahoo.com - April 18 at 12:59 PMWhy InVivo Therapeutics Stock Falling?nasdaq.com - April 15 at 8:14 AMInVivo Therapeutics Announces 1-for-25 Reverse Stock Splitmarketwatch.com - April 14 at 10:13 PMInVivo Therapeutics stock sinks after 1-for-25 reverse stock split announcedfinance.yahoo.com - April 14 at 10:13 PMInVivo Therapeutics slumps 7% on 1-for-25 reverse stock splitseekingalpha.com - April 14 at 5:12 PMSidekick Health: DTx leader Sidekick announces key C-level hires in move to accelerate U.S. market growthfinanznachrichten.de - February 8 at 10:34 AMDTx leader Sidekick announces key C-level hires in move to accelerate U.S. market growthfinance.yahoo.com - February 8 at 10:34 AMInVivo Therapeutics Holdings(NVIV)fool.com - January 30 at 6:01 PMInVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright BioConnect Conferencefinance.yahoo.com - January 6 at 8:30 AMInVivo Therapeutics Holdings Corp Shares Fall 1.4% Below Previous 52-Week Low - Market Movernasdaq.com - December 29 at 1:16 AMInVivo Therapeutics Holdings Corp Shares Close the Day 11.0% Lower - Daily Wrapnasdaq.com - December 29 at 1:16 AMInVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conferencefinance.yahoo.com - September 9 at 4:17 PMInVivo Therapeutics Announces 75% Target Enrollment Achieved for the INSPIRE 2.0 Spinal Cord Injury Studyfinance.yahoo.com - September 8 at 9:14 AMInVivo Therapeutics Holdings Corp 04ICmorningstar.com - August 20 at 11:14 PMInVivo Therapeutics Holdings Corp Common Stock (NVIV)nasdaq.com - August 7 at 10:38 PM Get InVivo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NVIV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MOTS News TTOO News DYNT News INBS News INVO News QNRX News SINT News BJDX News RMED News AVGR News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:NVIV) was last updated on 5/31/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InVivo Therapeutics Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.